http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20010997-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b65747ed78f05dd9ebe107b50ce2855 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 |
| filingDate | 2000-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc453b0120e8889ff031364ea4bff8c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3660793ce7c106d8fef7cd24cf66e75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_496f8afe7a87339888be578e8a910a81 |
| publicationDate | 2001-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | PE-20010997-A1 |
| titleOfInvention | CAST RING COMPOUND |
| abstract | REFERS TO A THERAPEUTIC AGENT FOR HEPATITIS C WHICH INCLUDES A CAST RING COMPOUND OF FORMULA I WHERE G1 IS C (-R1), N; G2 IS C (-R2), N; G3 IS C (-R3), N; G4 IS C (-R4), N; G5, G6, G9, G8 ARE C, N; G7 IS C (-R7), O, S, N OPTIONALLY SUBSTITUTED WITH R8; R1, R2, R3, R4 ARE N, ALCANOYL C1-C6, CARBOXYL, CYANE, NITRO, ALKYL C1-C6, COORa1, CONRa2Ra3, C (= NRa4) NH2, NHRa5, ORa6, SO2Ra7, POO (Ra31) 2, BETWEEN OTHERS; Ra1 IS C1-C6 ALKYL; Ra2, Ra3 ARE H, C1-C6 ALCOXY, C1-C6 ALKYL; Ra4 IS H, OH; Ra5 IS H, C1-C6 ALCANOYL, C1-C6 ALKYLSULFONYL; Ra6 IS H, C1-C6 ALKYL; Ra7 IS OH, AMINO, C1-C6 ALKYL, C1-C6 ALKYLAMINE; Ra31 IS H, C1-C6 ALKYL; Cy RING IS C3-C8 CYCLOALKYL, C3-C8 CYCLOALKENYL; RING A IS C6-C14 ARYL, C3-C8 CYCLOALKYL, C3-C8 CYCLOALKENYL, HETEROCYCLE; R5 AND R6 ARE H, HALOGEN, C1-C6 ALKYL, ORa8; X IS H, HALOGEN, CYANE, NITRO, AMINE, C1-C6 ALKYLSULFONYL, AMONG OTHERS. A PREFERRED COMPOUND IS ETHYL 2- [4- (3-BROMOPHENOXY) PHENYL] -1-CYCLOHEXYLBENZIMIDAZOLE-5-CARBOXYLATE. THE COMPOUND INHIBITES HEPATITIS C POLYMERASE |
| priorityDate | 1999-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.